Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 1;129(5):664-667.
doi: 10.1002/cncr.34598. Epub 2022 Dec 28.

Cancer trials as opportunities to serve and learn from individuals with human immunodeficiency virus

Christina E Henson  1 , Daniel J Morton  2   3 , Jyoti S Mayadev  4 , Stuart J Wong  5 , Dmitriy Zamarin  6
Affiliations

Cancer trials as opportunities to serve and learn from individuals with human immunodeficiency virus

Christina E Henson et al. Cancer. .
No abstract available

Keywords: anal cancer; cervical cancer; clinical trials; head and neck cancer; human immunodeficiency virus (HIV); person living with human immunodeficiency virus (PLWH).

PubMed Disclaimer

Conflict of interest statement

Jyoti S. Mayadev reports consulting for Varian Medical Systems, Merck, Primmune, and AstraZeneca. Dmitriy Zamarin reports consulting for Calidi Biotherapeutics, Celldex Therapeutics, AstraZeneca, Crown Biosciences, Xencor, Mana Therapeutics, Memgen, Tessa Therapeutics, Synthekine, Hookipa Biotech, Genentech, Accurius, ImmunOs Therapeutics, and GlaxoSmithKline; patents with Merck; and grants/contracts from Synthekine, Plexxikon, AstraZeneca, and Genentech. The other authors made no disclosures.

References

    1. Guidelines regarding the inclusion of cancer survivors and HIV-positive individuals on clinical trials. National Cancer Institute. Updated October 8, 2019. Accessed June 15, 2022. https://ctep.cancer.gov/protocolDevelopment/policies_hiv.htm
    1. Persad GC, Little RF, Grady C. Including persons with HIV infection in cancer clinical trials. J Clin Oncol. 2008;26(7):1027–1032. doi:10.1200/jco.2007.14.5532 - DOI - PubMed
    1. Uldrick TS, Ison G, Rudek MA, et al. Modernizing clinical trial eligibility criteria: recommendations of the American Society of Clinical Oncology–Friends of Cancer Research HIV Working Group. J Clin Oncol. 2017;35(33):3774–3780. doi:10.1200/jco.2017.73.7338 - DOI - PMC - PubMed
    1. Cancer clinical trial eligibility criteria: patients with HIV. hepatitis B virus, or hepatitis C virus infections. US Food and Drug Administration. July 2020. Accessed December 19, 2022. https://www.fda.gov/regulatory-information/search-fda-guidance-documents...
    1. Suneja G, Boyer M, Yehia BR, et al. Cancer treatment in patients with HIV Infection and non–AIDS-defining cancers: a survey of US oncologists. J Oncol Pract. 2015;11(3):e380–e387. doi:10.1200/jop.2014.002709 - DOI - PMC - PubMed

Publication types